Recombinant Human Adenovirus Type 5 injection
XJTU1AF2021LSK-160
Approved small_molecule active
Quick answer
Recombinant Human Adenovirus Type 5 injection for Hepatocellular Carcinoma is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Hepatocellular Carcinoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- active